Clinical investigation of plasma-derived antithrombin products

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/BPWG/2220/99
Published17/01/2002
Effective from01/07/2002
Keywords Congenital antithombin deficiency, acquired antithombin deficiency
DescriptionThis document summarises the clinical trials required for authorisation of new and modified human plasma derived antithrombin products.



Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more